Literature DB >> 3887899

Pathophysiology of experimental renovascular hypertension.

E G Nabel, G H Gibbons, V J Dzau.   

Abstract

The genesis of renovascular hypertension follows a continuum from an acute to a chronic phase. Reduction in renal perfusion initiates renin release and angiotensin-mediated systemic vasoconstriction. Aldosterone secretion, sodium and water retention, and expansion of the extracellular volume ensue. Sustained hypertension is further maintained by interacting physiologic mechanisms including increased angiotensin II sensitivity, vasopressin, ouabain-like substance, the sympathetic nervous system, CNS mechanisms, autoregulation, and structural changes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887899     DOI: 10.1016/s0272-6386(85)80073-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  2014 Association of American Physicians George M. Kober Medal. Introduction of Elizabeth G. Nabel.

Authors:  Eugene Braunwald
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

2.  The current state of endovascular therapy in the evaluation and management of renovascular disease.

Authors:  Praveen R Anchala; Scott A Resnick
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

Review 3.  Evaluation and management of bilateral renal artery stenosis in children: a case series and review.

Authors:  D Ellis; R Shapiro; V P Scantlebury; R Simmons; R Towbin
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.